168 related articles for article (PubMed ID: 18729739)
1. Interferon-alpha2b restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by modulating CXC receptor ligand interaction.
Chakraborty K; Bose A; Pal S; Chattopadhyay U; Baral R
J Interferon Cytokine Res; 2008 Aug; 28(8):487-99. PubMed ID: 18729739
[TBL] [Abstract][Full Text] [Related]
2. Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance.
Chakraborty K; Bose A; Pal S; Sarkar K; Goswami S; Ghosh D; Laskar S; Chattopadhyay U; Baral R
Int Immunopharmacol; 2008 Feb; 8(2):330-40. PubMed ID: 18182249
[TBL] [Abstract][Full Text] [Related]
3. CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid.
Manousou P; Kolios G; Drygiannakis I; Koulentaki M; Pyrovolaki K; Voumvouraki A; Notas G; Bourikas L; Papadaki HA; Kouroumalis E
Clin Exp Immunol; 2013 Apr; 172(1):9-15. PubMed ID: 23480180
[TBL] [Abstract][Full Text] [Related]
4. Functional Analysis of CXCR3 Splicing Variants and Their Ligands Using NanoBiT-Based Molecular Interaction Assays.
Nguyen HT; Hurh S; Nguyen LP; Nguyen TU; Park HK; Seong JY; Lee CS; Ham BJ; Hwang JI
Mol Cells; 2023 May; 46(5):281-297. PubMed ID: 36799104
[TBL] [Abstract][Full Text] [Related]
5. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils.
Gasperini S; Marchi M; Calzetti F; Laudanna C; Vicentini L; Olsen H; Murphy M; Liao F; Farber J; Cassatella MA
J Immunol; 1999 Apr; 162(8):4928-37. PubMed ID: 10202039
[TBL] [Abstract][Full Text] [Related]
6. Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.
Dengel LT; Norrod AG; Gregory BL; Clancy-Thompson E; Burdick MD; Strieter RM; Slingluff CL; Mullins DW
J Immunother; 2010; 33(9):965-74. PubMed ID: 20948440
[TBL] [Abstract][Full Text] [Related]
7. The role of CXCR3 and its ligands expression in Brucellar spondylitis.
Hu X; Shang X; Wang L; Fan J; Wang Y; Lv J; Nazierhan S; Wang H; Wang J; Ma X
BMC Immunol; 2020 Nov; 21(1):59. PubMed ID: 33208100
[TBL] [Abstract][Full Text] [Related]
8. Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis.
Proost P; Vynckier AK; Mahieu F; Put W; Grillet B; Struyf S; Wuyts A; Opdenakker G; Van Damme J
Eur J Immunol; 2003 Nov; 33(11):3146-53. PubMed ID: 14579283
[TBL] [Abstract][Full Text] [Related]
9. Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer.
Bronger H; Kraeft S; Schwarz-Boeger U; Cerny C; Stöckel A; Avril S; Kiechle M; Schmitt M
Breast Cancer Res; 2012 Feb; 14(1):R30. PubMed ID: 22333315
[TBL] [Abstract][Full Text] [Related]
10. CXCR3 ligands in disease and therapy.
Van Raemdonck K; Van den Steen PE; Liekens S; Van Damme J; Struyf S
Cytokine Growth Factor Rev; 2015 Jun; 26(3):311-27. PubMed ID: 25498524
[TBL] [Abstract][Full Text] [Related]
11. Interferon alpha2b augments suppressed immune functions in tobacco-related head and neck squamous cell carcinoma patients by modulating cytokine signaling.
Bose A; Ghosh D; Pal S; Mukherjee KK; Biswas J; Baral R
Oral Oncol; 2006 Feb; 42(2):161-71. PubMed ID: 16249117
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.
Wang XX; Wang QQ; Wu JQ; Jiang M; Chen L; Zhang CF; Xiang LH
Br J Dermatol; 2016 Jun; 174(6):1318-26. PubMed ID: 26801009
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of interferon alpha inducible genes in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus and healthy donors.
MacParland SA; Corkum CP; Burgess C; Karwowska S; Kroll W; Michalak TI
Int Immunopharmacol; 2015 Apr; 25(2):545-52. PubMed ID: 25765354
[TBL] [Abstract][Full Text] [Related]
14. CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo.
Wennerberg E; Kremer V; Childs R; Lundqvist A
Cancer Immunol Immunother; 2015 Feb; 64(2):225-35. PubMed ID: 25344904
[TBL] [Abstract][Full Text] [Related]
15. CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways.
Berchiche YA; Sakmar TP
Mol Pharmacol; 2016 Oct; 90(4):483-95. PubMed ID: 27512119
[TBL] [Abstract][Full Text] [Related]
16. IFNalpha2b stimulated release of IFNgamma differentially regulates T cell and NK cell mediated tumor cell cytotoxicity.
Bose A; Baral R
Immunol Lett; 2007 Jan; 108(1):68-77. PubMed ID: 17112599
[TBL] [Abstract][Full Text] [Related]
17. [Expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells induced by IFN-γ].
Lin Q; Song Y; Zhu X; Yang S; Zheng J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):137-40. PubMed ID: 23388331
[TBL] [Abstract][Full Text] [Related]
18. Recruitment of natural killer cells in advanced stages of endogenously arising B-cell lymphoma: implications for therapeutic cell transfer.
Przewoznik M; Hömberg N; Naujoks M; Pötzl J; Münchmeier N; Brenner CD; Anz D; Bourquin C; Nelson PJ; Röcken M; Mocikat R
J Immunother; 2012 Apr; 35(3):217-22. PubMed ID: 22421939
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration.
Witte E; Kokolakis G; Witte K; Warszawska K; Friedrich M; Christou D; Kirsch S; Sterry W; Volk HD; Sabat R; Wolk K
J Mol Med (Berl); 2016 Apr; 94(4):391-400. PubMed ID: 26612594
[TBL] [Abstract][Full Text] [Related]
20. CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease.
Wenzel J; Lucas S; Zahn S; Mikus S; Metze D; Ständer S; von Stebut E; Hillen U; Bieber T; Tüting T
J Am Acad Dermatol; 2008 Mar; 58(3):437-42. PubMed ID: 18280341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]